Development of Positron Emission Tomography Radiotracers for the GABA Transporter 1

ACS Chemical Neuroscience
Alexandra R SowaM R Kilbourn

Abstract

In vivo positron emission tomography (PET) imaging of the γ-aminobutyric acid (GABA) receptor complex has been accomplished using radiolabeled benzodiazepine derivatives, but development of specific presynaptic radioligands targeting the neuronal membrane GABA transporter type 1 (GAT-1) has been less successful. The availability of new structure-activity studies of GAT-1 inhibitors and the introduction of a GAT-1 inhibitor (tiagabine, Gabatril) into clinical use prompted us to reinvestigate the syntheses of PET ligands for this transporter. Initial synthesis and rodent PET studies of N-[11C]methylnipecotic acid confirmed the low brain uptake of that small and polar molecule. The common design approach to improve blood-brain barrier permeability of GAT-1 inhibitors is the attachment of a large lipophilic substituent. We selected an unsymmetrical bis-aromatic residue attached to the ring nitrogen by a vinyl ether spacer from a series recently reported by Wanner and coworkers. Nucleophilic aromatic substitution of an aryl chloride precursor with [18F]fluoride was used to prepare the desired candidate radiotracer ( R, E/ Z)-1-(2-((4-fluoro-2-(4-[18F]fluorobenzoyl)styryl)oxy)ethyl)piperidine-3-carboxylic acid (( R, E/ Z)-[18F]10). P...Continue Reading

References

Jan 1, 1992·Life Sciences·P D SuzdakC Braestrup
Jan 1, 1990·International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes·M R KilbournV E Gregor
Jan 1, 1990·Journal of Pharmaceutical Sciences·R GokhaleJ D Wood
Nov 1, 1984·Journal of Pharmaceutical Sciences·A M CriderK Seibert
Jan 10, 1997·The Journal of Biological Chemistry·E R Bennett, B I Kanner
Mar 27, 1999·Epilepsy Research·I E LeppikK W Sommerville
May 7, 1999·Journal of Pharmaceutical Sciences·F P BoninaP de Caprariis
Jan 22, 2000·Brain Research·I S ErikssonJ Marcusson
Jan 23, 2002·Neuropsychobiology·Ingrid Sundman-ErikssonJan Marcusson
Nov 3, 2004·Seizure : the Journal of the British Epilepsy Association·Xiaolan WangPhilip N Patsalos
Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Hassan Pajouhesh, George R Lenz
Jun 29, 2006·Aging Clinical and Experimental Research·Ingrid Sundman-Eriksson, Per Allard
Dec 23, 2009·Pharmacology & Therapeutics·Karsten K MadsenArne Schousboe
May 22, 2010·ChemMedChem·Søren SkovstrupFlemming Steen Jørgensen
Jul 27, 2012·Journal of Pharmaceutical Sciences·Fatma Goksin BaharTeruko Imai
Nov 29, 2012·Nuclear Medicine Communications·Olaf SchijnsGovert Hoogland
Nov 29, 2013·Journal of Labelled Compounds & Radiopharmaceuticals·Jan D Andersson, Christer Halldin
Oct 2, 2014·Accounts of Chemical Research·Genevieve C Van de BittnerJacob M Hooker
Mar 12, 2016·Journal of Medicinal Chemistry·Pierrik LassalasCarlo Ballatore
Aug 25, 2016·Molecular Imaging·Benjamin H RotsteinNeil Vasdev
Aug 23, 2017·Seminars in Nuclear Medicine·Michael R Kilbourn
Oct 4, 2017·Frontiers in Neuroanatomy·Karl Zilles, Nicola Palomero-Gallagher

❮ Previous
Next ❯

Citations

Aug 28, 2021·ACS Chemical Neuroscience·Chris HoffmannBernd Neumaier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.